Evidence map›Paper›PMID 24107359›Full record

ArticleEpidemiology and infection2014

Increased incidence of Campylobacter jejuni-associated Guillain-Barré syndromes in the Greater Paris area.

V Sivadon-Tardy, R Porcher, D Orlikowski, E Ronco, E Gault, J Roussi, M-C Durand, T Sharshar, D Annane, J-C Raphael and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Global Epidemiology of Campylobacter Infection.Clinical microbiology reviews · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

V Sivadon-TardyAssistance Publique-Hôpitaux de Paris (AP-HP), hôpital Ambroise Paré, Boulogne-Billancourt, France; andUniversité de Versailles - Saint-Quentin-en-Yvelines (UVSQ),France.
R PorcherAP-HP, hôpital St Louis, Paris, France; andUniversité Paris Diderot,Paris,France.
D OrlikowskiAP-HP, hôpital Raymond Poincaré, Garches,France; andUVSQ.
E RoncoAP-HP, hôpital Raymond Poincaré, Garches,France; andUVSQ.
E GaultAssistance Publique-Hôpitaux de Paris (AP-HP), hôpital Ambroise Paré, Boulogne-Billancourt, France; andUniversité de Versailles - Saint-Quentin-en-Yvelines (UVSQ),France.
J RoussiAP-HP, hôpital Raymond Poincaré, Garches,France; andUVSQ.
M-C DurandAP-HP, hôpital Raymond Poincaré, Garches,France; andUVSQ.
T SharsharAP-HP, hôpital Raymond Poincaré, Garches,France; andUVSQ.
D AnnaneAP-HP, hôpital Raymond Poincaré, Garches,France; andUVSQ.
J-C RaphaelAP-HP, hôpital Raymond Poincaré, Garches,France; andUVSQ.
F MegraudUniversité Bordeaux Segalen,Centre National de Référence des Campylobacters et Helicobacter, Bordeaux,France.
J-L GaillardAssistance Publique-Hôpitaux de Paris (AP-HP), hôpital Ambroise Paré, Boulogne-Billancourt, France; andUniversité de Versailles - Saint-Quentin-en-Yvelines (UVSQ),France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of Campylobacter jejuni as the triggering agent of Guillain-Barré syndrome (GBS) has not been reassessed since the end of the 1990s in France. We report that the number of C. jejuni-related GBS cases increased continuously between 1996 and 2007 in the Paris region (mean annual increment: 7%, P = 0·007).

Indexed as

AdultAgedCampylobacter InfectionsCampylobacter jejuniFemaleFranceGuillain-Barre SyndromeHumansIncidenceMaleMiddle AgedParis

Identifiers

PMID24107359
PMCPMC9151207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.